Overview of Dr. Schenck
Dr. Edward Schenck is a pulmonologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Lower Manhattan Hospital. He received his medical degree from Lewis Katz School of Medicine at Temple University and has been in practice 11 years. He is one of 238 doctors at New York-Presbyterian Hospital and one of 40 doctors at NewYork-Presbyterian/Lower Manhattan Hospital who specialize in Pulmonology. He has more than 90 publications and over 500 citings.
Office
525 E 68th St
# 96
New York, NY 10065Fax+1 646-962-0110
Education & Training
- NYU Grossman School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2009 - 2010
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2006 - 2009
- Lewis Katz School of Medicine at Temple UniversityClass of 2006
Certifications & Licensure
- NY State Medical License 2008 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Mitochondrial DNA as a Biomarker of Sepsis Severity Start of enrollment: 2017 Feb 10
Roles: Contact
Publications & Presentations
PubMed
- 18 citationsCritical carE Database for Advanced Research (CEDAR): An automated method to support intensive care units with electronic health record data.Edward J. Schenck, Katherine Hoffman, Marika M. Cusick, Joseph Kabariti, Evan Sholle
Journal of Biomedical Informatics. 2021-04-14 - 1478 citationsClinical Characteristics of Covid-19 in New York City.Parag Goyal, Justin J Choi, Laura C. Pinheiro, Edward J. Schenck, Ruijun Chen
The New England Journal of Medicine. 2020-04-17 - 74 citationsData-driven identification of post-acute SARS-CoV-2 infection subphenotypes.Hao Zhang, Chengxi Zang, Zhenxing Xu, Yongkang Zhang, Jie Xu
Nature Medicine. 2023-01-01
Journal Articles
- Association Between Early Treatment with Tocilizumab and Mortality Among Critically Ill Patients with COVID-19Kusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Diana Finkel, Mary Mallappallil..., JAMA Internal Medicine
- Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USKusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Alexandre M Shehata, Nitender G..., JAMA Internal Medicine
- Risk of Ischemic Stroke in Patients with Coronavirus Disease 2019 (COVID-19) vs Patients with InfluenzaAlexander E Merkler, Neal S Parikh, Saad Mir, Hooman Kamel, Eaton Lin, Joshua Lantos, Edward J Schenck, Parag Goyal, Santosh B Murthy, Costantino Iadecola, Alan Z Sega..., JAMA Neurology
Authored Content
- Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USJuly 2020
- Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USJuly 2020
- Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USJuly 2020
- Risk of Ischemic Stroke in Patients with Coronavirus Disease 2019 (COVID-19) vs Patients with InfluenzaJuly 2020
- Risk of Ischemic Stroke in Patients with Coronavirus Disease 2019 (COVID-19) vs Patients with InfluenzaJuly 2020
- Join now to see all
Press Mentions
- COVID May Trigger Hyperglycemia by Harming Fat CellsOctober 4th, 2021
- COVID-19 May Trigger Hyperglycemia and Worsen Disease by Harming Fat CellsOctober 1st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: